Can an anti-inflammatory drug (IL-1Ra) given into the skin reduce damaging inflammation in the brain and body after stroke compared to a dummy-drug?
Can stem cells be used to reduce the damage of inflammation after stroke and promote brain repair?
This research aims to improve outcomes for Intracerebral Haemorrhage (ICH) patients by developing new emergency treatments to reduce swelling in the brain after ICH, and improving the care that patients receive.
Inflammation is an important defence mechanism that the body uses in response to injury or infection. However, it can also be highly damaging to the brain directly after stroke. This study will investigate whether adult stem cells can be transformed and used to reduce inflammation in the brain after stroke, and promote recovery.
Published in the journal Stroke, a new study suggests that a drug commonly used to treat rheumatoid arthritis may help reduce harmful inflammation in the brain after stroke. The study was funded by the Stroke Association.
The effect of blood pigments on brain inflammation and survival of nerve cells.
Our annual Keynote Lecture showcases some of the latest advancements being made in stroke research.
This year’s Keynote Lecture was delivered by Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester. Professor Rothwell is one of the UK’s leading neuroscientists whose research focuses on inflammation in brain disease, especially stroke.